NeilM.KogutMD

Oncology • Los Angeles, CA

Director of Transplantation Kaiser Permanente Southern California

Join to view full profile

Dr. Kogut is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kogut's full profile

Already have an account?

Office
4733 W Sunset Blvd
Los Angeles, CA 90027
Phone+1 323-783-4011

Education & Training

City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1985
Kaiser Permanente Southern California (Los Angeles)Fellowship, Hematology and Medical Oncology, 1982 - 1984
Kaiser Permanente Southern California (Los Angeles)Residency, Internal Medicine, 1979 - 1982
Keck School of Medicine of the University of Southern CaliforniaClass of 1979

Certifications & Licensure

CA State Medical License 1980 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Distinction in General Scholarship University of California at Berkeley, California, 1973

Publications & Presentations

PubMed

1 citations
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation.
Erik L Lum, Nima Nassiri, Neil Kogut, Caspian Oliai, Anne Raldow
Lancet. 2024-10-05
Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance.
Rebecca A Sosa, Thomas Mone, Bita V Naini, Donald B Kohn, Elaine F Reed
Transplantation. 2023-02-01
Immune tolerance induction through haematopoietic chimerism after kidney donation.
Nima Nassiri, Erik Lum, Monica D Mead, Ann C Raldow, Neil Kogut
Lancet. 2022-08-06

Abstracts/Posters

Reduced-Intensity Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia
Stein, A., O'Donnell, M., Snyder, D., Parker, P., Nademanee, A., Falk, P., Kogut, N., Rosenthal, J., Palmer, J., Tsai, N., Forman, S., Biology of Blood and Marrow Transplantation, 2/1/2007
Feasibility and Toxicity of Maintenance Thalidomide Following Single Cycles Autologous PBSC Transplant in Patients with Multiple Myeloma
Sahebi, F., Somlo, G., Kogut, N., Blood, 11/1/2003
A Fludarabine/Melphalan (Flu/Mel) Reduced Intensity Conditioning Regimen with Cyclosporine and Mycophenolate Mofetil 9CSA/MMF) Allows Successful Transplantation of Pat...
Rodriguez, R., Parker, P., Nademanee, A., Smith, D. Stein, A., Snyder, D.S., O'Donnell, M.R., Molina, A., Bhatia, R., Fung, H.C., Krishnan, A.Y., Popplewell, L., Cohen..., BMT Program, Blood, Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope, Duarte,, 11/16/2002
Reduced Intensity Allogeneic Stem Cell Transplantation for Patients Who Have Failed a Prior Autologous Stem Cell Transplant
Cohen, S., Fung, H., Stein, A., Nademanee, A., Rodriguez, R., O'Donnell, M., Parker, P., Molina, A., Margolin, K., Somlo, G., Sahebi, F., Spielberger, R., Snyder, D., ..., BMT Program, Blood, Hematology/Bone Marrow Transplantation, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Pe, 11/16/2002
Long Term Follow-Up Report on Allogeneic Stem Cell Transplantation (alloSCT) for patients with Acute Myelogneous Leukemia (AML) in First Relapse (Rel) or 2nd Complete ...
Fung, H.C., Cohen, S., Dagis, A., O'Donnell, M., Falk, P., Kogut, N., Krishnan, A., Molina, A., Nademanee, A., Parker, P., Popplewell, L., Rodriguez, R., Slovak, M., S..., BMT Program, Blood, Div of Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope, , 11/16/2002
Autologous Peripheral Stem Cell Transplantation (ABSCT) for Adult Patient with Hodgkin's Disease (HD); Impact of Mobilization Kinetics on Transplant Outcome
Fung, H.C., Wang, S., Nademanee, A., Cohen, S., O'Donnell, M., Falk, P., Kogut, N., Krishnan, A., Molina, A., Parker, P., Popplewell, L., Rodriguez, R., Sahebi, F., Sm..., BMT Program, Blood, Div of Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope, , 11/16/2002
Allogeneic Peripheral-Blood Cells Transplantation for Patients with Acute Leukemia in First Remission
Fung HC, Snyder DS, Smith D, Gilfillan K, Molina A, O'Donnell M, Nademanee A, Parker P, Stein A, Falk P, Kogut N, Spielberger R, Cohen S, Sweetman R, Popplewell L, Rod..., Blood, 1/1/2001
Allogeneic Stem Cell Transplantation (SCT) for Patients with Primary Refractory Acute Myelogenous Leukemia (AML): Impact of Cytogenetic Risk Group on the Transplant Ou...
Fung HC, O'Donnell M, Popplewell L, Stein A, Nademanee A, Parker P, Slovak ML, Molina A, Smith D, Gilfillan K, Snyder DS, Krishnan A, Rodriguez R, Somlo G, Kogut N, Fa..., Blood, 1/1/2001
Intensified Cytoreduction with High Dose Melphalan (HDM) And Stem Cell Rescue (STR) Followed by a 2nd High Dose Therapy (HDT) And Autologous Stem Cell Transplant (ASCT...
Fung HC, Nademanee A, Stiff P, Molina A, Falk P, Kogut N, O'Donnell MR, Forman E, Ivers B, Rosenthal J, Vora N, Dagis A, Goldfarb P, Schriber J, Forman SJ, Blood, 1/1/2000
Amifostine (AMI) Before FTBI, Followed by VP-16 Cytoxan (CY) and Autologous PBSCT for Patients with Relapsed NHL, HD and Acute Leukemia: Toxicity Analysis
Rodriguez R, Nademanee A, Ivers B, Shear J, Bonner L, Frankel P, Molina A, Fung H, Snyder DS, O'Donnell, Spielberger R, Stein AS, Parker PM, Kashyap, Krishnan AY, Popp..., Blood, 1/1/1999
Extracorporeal Photopheresis (EP) is Effective Treatment for Chronic Refractory Graft-Versus-Host Disease (GvHD)
Sniecinski I, Parker P, Dagis A, Collier T, Wang S, Rickard K, Snyder D, Nademanee A, Spielberger R, Rodriguez R, Krishnan A, Fung H, Stein A, O'Donnell M, Rosenthal J..., Blood, 1/1/1998
The Detection of KSHV Is Increased by Mobilization Chemotherapy and Reduced in Autografts by CD34-seclection
R Vescio, C Wu, M Rettig, A Stewart, O Ballester, S Noga, H Rugo, C freytes, N Kogut, S Tarantolo, P Stiff, L Pinero, W Dalton, A Ho, G Schiller, M Benyunes, C Jacobs,..., Blood, 11/18/1997
A Phase III Study Evaluation CD34+Selected versus Unselected Autologous Peripheral Blood Progenitor Cell Transplantation for Patients with Advanced Multiple Myeloma: E...
G Shiller, AK Stewart, O Ballester, S Noga, H Rugo, C Freytes, E Stadtmauer, N Kogut, S Tarantolo, P Stiff, L. Pineiro, W Dalton, A Ho, R Vescio, M Benyunes, C Jacobs,..., Blood, 11/18/1997
Myeloma Cell Tumor Reduction in PCPC Autographs following CD34 Selection: The Results of a Phase III Trial Using the CEPARATE(R) Device
R Vescio, A Stewart, O Ballester, S Noga, H Rugo, C Freytes, E Stadtmauer, N Kogut, S Tarantolo, P Stiff, L. Pinero, W Dalton, A Ho, G Schiller, M Benyunes, C Jacobs, ..., Blood, 11/18/1997
Increase in Circulating Tumor Cell Burden during Mobilization Chemotherapy Predicts for Relapse after Autologous Transplantation in Multiple Myeloma Patients
A Stewart, O Ballester, S Noga, H Rugo, C Reytes, E Stadtmauer, N Kogut, S Tarantolo, P Stiff, L Pinero, W Dalton, A Ho, G Schiller, M Benyunes, C Jacobs, J DiPersio, ..., Blood, 11/18/1997
Autologous Stem Cell Transplantation (ASCT) in 100 Patients with Hodgkin's Disease (HD) in First Relapse (1st Rel): Impact of the Conditioning Regimen (Fractionated To...
Fung, H.C., Nademanee, A., Molina, A., Ruel, C., Ivers, B., Smith, D., Krishnan, A., Popplewell, L., Vora, N., Snyder, D., O'Donnell, M., Parker, P., Stein, A., Somlo,..., Blood, Autologous Stem Cell Transplantation (ASCT) in 100 Patients with Hodgkin's Disease (HD) in First Rel
Use of Oral Ganciclovir (PO-GCV) For the Preemptive Treatment (TX) Of CMV following Allogeneic HCT: Safety and Feasibility Results
Spielberger R, Szia J, Nelson RA, Newman E, Gallez-Hawkins G, Ahlers A, Stevenson J, Acedo C, Alam A, Bhatia R, Cohen S, Falk P, Fung HC, Kashyap A, Kogut N, Krishnan ..., Blood
Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM)
Firoozeh Sahebi, Neil M. Kogut, Ricardo Spielberger, peter M. Falk, Auayporn P. Nademanee, Leslie Popplewell, David G. Maloney, Roberto Rodriguez, Amrita Krishnan, Ryo..., Blood, Div of Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope,
Join now to see all

Lectures

Update on Stem Cell Transplantation, Grand Rounds
VA Wadsworth - 9/1/2000